Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTAIH.L Regulatory News (TAIH)

  • There is currently no data for TAIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Mar 2011 11:02

RNS Number : 9657C
Taihua Plc
15 March 2011
 



TAIHUA PLC

("Taihua" or "the Company")

TRADING UPDATE

Taihua plc, a China-based pharmaceutical company which manufactures Paclitaxel, Homoharringtonine and Traditional Chinese Medicines, would like to update its shareholders on its progress in 2010 before the release of its financial results for the 12 months ended 31 December 2010

Active Pharmaceutical Ingredients (APIs)

As disclosed in the AGM Statement of 30 June 2010 and the 2010 Interim Results the Company enjoyed a year of stable trading of Paclitaxel, Homoharringtonine and TCMs in the first half of 2010. This stable trading continued throughout the second half of the year

The Company's sales in 2010 for its APIs were as follows:

Paclitaxel 14,970g (2009 11,555g)

Homoharringtonine 7,200g (2009 5,190g)

2010 sales were at the same prices per gram as the second half of 2009

Traditional Chinese Medicines (TCMs)

Total Sales 2010 RMB 4.2m (2009 RMB 3.7m)

Balance Sheet

During the year the Company recovered the deposit it had paid in respect of new offices, generating RMB 14.6m of positive cashflow.

Working capital requirements were stable during the year so the Company's Balance Sheet remained strong at the end of the year

Outlook

We expect our non-Forsythia TCM sales to increase in 2011 due to the Bing Tong Pian distribution agreement and the recruitment of five new salesmen who will specifically target TCM distributors

The final RMB 11m payment in respect of the Forsythia lease is expected to be made in the next month. We understand that retail pricing of Forsythia has remained stable since our announcement of this agreement

In the year ahead, Paclitaxel sales to our existing Russian and South American markets and Homoharringtonine sales to our existing Chinese market are expected to remain stable both in terms of volumes and pricing.

The Company continues to seek an appropriate distributor to enable to progress European sales of Pacliataxel. The Company is also investigating international Homoharringtonine opportunities

For more information please contact:

Nicholas Lyth, Taihua plc

0776 990 6686

Katy Mitchell, WH Ireland Limited

+44 161 832 2174

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFILVIIELIL
Date   Source Headline
26th Apr 20175:17 pmRNSHolding(s) in Company
21st Apr 20174:15 pmRNSResult of GM / Cancellation of Admission
5th Apr 20177:00 amRNSProposed cancellation of Admission & Notice of AGM
9th Mar 20174:13 pmRNSHolding(s) in Company
7th Mar 20172:01 pmRNSCancellation of Tender Offer Shares
22nd Feb 20172:00 pmRNSResult of Tender Offer and Directors' Interests
22nd Feb 20177:00 amRNSResult of Tender Offer and Directors' Interests
6th Feb 20173:41 pmRNSProposed Tender Offer
30th Jan 20171:39 pmRNSTrading Update re Forsythia
18th Jan 20173:14 pmRNSAIM Rule 26 Website update
12th Jan 20173:44 pmRNSAIM Rule 26 Website update
11th Jan 201711:00 amRNSAIM Rule 26 Website
10th Jan 20173:57 pmRNSAIM Rule 26 Website
13th Oct 20164:21 pmRNSHolding(s) in Company
30th Sep 20168:16 amRNSHalf-year Report
19th Sep 201611:45 amRNSHolding(s) in Company
16th Sep 20164:29 pmRNSResults of Open Offer
26th Aug 20164:09 pmRNSChange of Nominee Holding
26th Aug 201611:37 amRNSHolding(s) in Company
25th Aug 20167:00 amRNSOpen Offer & Posting of Circular to Shareholders
30th Jun 20164:52 pmRNSFinal Results
23rd May 20163:40 pmRNSUpdate
25th Apr 20168:52 amRNSHolding(s) in Company
25th Apr 20168:50 amRNSHolding(s) in Company
6th Apr 20167:00 amRNSTrading Update
26th Jan 20163:20 pmRNSRenewal of Drug Production Permit
21st Jan 20164:22 pmRNSGMP certificate update / Production delay
18th Jan 20163:30 pmRNSHolding(s) in Company
30th Sep 201510:45 amRNSHalf Yearly Report
6th Aug 20157:00 amRNSRenewal of Chinese GMP certificate
27th Jul 20157:00 amRNSChange of Registered Office
30th Jun 20153:59 pmRNSPosting of Annual Report
30th Jun 20159:04 amRNSFinal Results
5th May 20157:01 amRNSUpdate
19th Feb 20159:03 amRNSTrading Update
6th Jan 20158:02 amRNSChange of Registered Office
30th Sep 20148:43 amRNSHalf Yearly Report
29th Jul 20142:21 pmRNSStrategy Update
27th Jun 20144:08 pmRNSFinal Results
25th Apr 201412:32 pmRNSClarification of Forsythia Market Pricing
28th Jan 20141:55 pmRNSTrading Update
30th Sep 20139:25 amRNSHalf Yearly Report
6th Sep 20139:00 amRNSNotification re UK Takeover Code
9th Jul 20133:18 pmRNSResult of AGM
27th Jun 20132:15 pmRNSChange of AGM Venue
14th Jun 201312:20 pmRNSFinal Results
3rd May 20137:48 amRNSChange of Registered Office
20th Mar 20139:04 amRNSTrading Update
4th Feb 20134:28 pmRNSUpdate on Forsythia Lease
18th Dec 20122:32 pmRNSUpdate on Lease

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.